|
Diabetes, Vol 44, Issue 11 1328-1333, Copyright © 1995 by American Diabetes Association
Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats
H Hosokawa, YA Hosokawa and JL Leahy
Division of Endocrinology, Diabetes, Metabolism, and Molecular Medicine, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.
Glucokinase is the beta-cell glucose sensor, i.e., the site in glucose
metabolism that determines the glucose set-point (sensitivity) for insulin
secretion. Hexokinase is also present, but it normally contributes little
to glucose metabolism because of end-product inhibition by glucose
6-phosphate. There is a lowered glucose set-point for insulin secretion in
90% pancreatectomized (Px) diabetic rats. We investigated the mechanism by
measuring hexokinase and glucokinase activity in islet extracts.
Glucokinase activity was minimally raised in Px islets (Vmax 125% of
sham-operated control rats). In contrast, hexokinase Vmax was 250% of the
control value, suggesting that the increased hexokinase activity caused the
beta-cell glucose hypersensitivity. Additional evidence was obtained with a
40-h fast that was performed because of a previous observation that the
inhibitory effect of fasting on insulin secretion was impaired in Px rats.
Glucokinase activity fell normally in the Px rats (32 +/- 4% reduction in
sham vs. 37 +/- 4% in Px rats) as opposed to hexokinase activity, which was
unaffected in either group. In summary, a feature of hyperglycemia is
upregulated islet hexokinase activity. The result is that hexokinase
assumes partial control over the glucose set-point for insulin secretion.
As such, regulatory effects on insulin secretion, such as fasting, that are
mediated through glucokinase activity may be altered.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Rukstalis, M. Ubeda, M. V. Johnson, and J. F. Habener
Transcription Factor Snail Modulates Hormone Expression in Established Endocrine Pancreatic Cell Lines
Endocrinology,
June 1, 2006;
147(6):
2997 - 3006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Maiztegui, M I Borelli, M L Massa, H Del Zotto, and J J Gagliardino
Enhanced expression of hexokinase I in pancreatic islets induced by sucrose administration.
J. Endocrinol.,
May 1, 2006;
189(2):
311 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stumvoll, P. A. Tataranni, N. Stefan, B. Vozarova, and C. Bogardus
Glucose Allostasis
Diabetes,
April 1, 2003;
52(4):
903 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A.G. Pertusa, R. Nesher, N. Kaiser, E. Cerasi, J.-C. Henquin, and J.-C. Jonas
Increased Glucose Sensitivity of Stimulus-Secretion Coupling in Islets From Psammomys obesus After Diet Induction of Diabetes
Diabetes,
August 1, 2002;
51(8):
2552 - 2560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kooptiwut, S. Zraika, A. W. Thorburn, M. E. Dunlop, R. Darwiche, T. W. Kay, J. Proietto, and S. Andrikopoulos
Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to {beta}-Cell Failure
Endocrinology,
June 1, 2002;
143(6):
2085 - 2092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Laybutt, A. Sharma, D. C. Sgroi, J. Gaudet, S. Bonner-Weir, and G. C. Weir
Genetic Regulation of Metabolic Pathways in beta -Cells Disrupted by Hyperglycemia
J. Biol. Chem.,
March 22, 2002;
277(13):
10912 - 10921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Q. Liu, P. W. Nevin, and J. L. Leahy
beta -Cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia
Am J Physiol Endocrinol Metab,
July 1, 2000;
279(1):
E68 - E73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Schuit, K. Moens, H. Heimberg, and D. Pipeleers
Cellular Origin of Hexokinase in Pancreatic Islets
J. Biol. Chem.,
November 12, 1999;
274(46):
32803 - 32809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Linn, C. Strate, and K. Schneider
Diet Promotes {beta}-Cell Loss by Apoptosis in Prediabetic Nonobese Diabetic Mice
Endocrinology,
August 1, 1999;
140(8):
3767 - 3773.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-C. Jonas, A. Sharma, W. Hasenkamp, H. Ilkova, G. Patane, R. Laybutt, S. Bonner-Weir, and G. C. Weir
Chronic Hyperglycemia Triggers Loss of Pancreatic beta Cell Differentiation in an Animal Model of Diabetes
J. Biol. Chem.,
May 14, 1999;
274(20):
14112 - 14121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hayakawa, M. Noda, K. Yasuda, H. Yorifuji, S. Taniguchi, I. Miwa, H. Sakura, Y. Terauchi, J.-i. Hayashi, G. W. G. Sharp, et al.
Ethidium Bromide-induced Inhibition of Mitochondrial Gene Transcription Suppresses Glucose-stimulated Insulin Release in the Mouse Pancreatic beta -Cell Line beta HC9
J. Biol. Chem.,
August 7, 1998;
273(32):
20300 - 20307.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|